Literature DB >> 2205944

The immunology of inflammatory bowel disease.

J R Lowes1, D P Jewell.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2205944     DOI： 10.1007/bf00197510

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  100 in total

1.  Lymphocytotoxic and RNA antibodies in inflammatory bowel disease: a comparative study in patients and their families.?

Authors:  S J Korsmeyer; R C Williams; I D Wilson; R G Strickland
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

2.  The cellular pathway of antigen presentation: biochemical and functional analysis of antigen processing in dendritic cells and macrophages.

Authors:  B M Chain; P M Kay; M Feldmann
Journal:  Immunology       Date:  1986-06       Impact factor: 7.397

3.  Endoscopic appearances of the rectal mucosa of patients with Crohn's disease visualised with a magnifying colonoscope.

Authors:  K Makiyama; M K Bennett; D P Jewell
Journal:  Gut       Date:  1984-04       Impact factor: 23.059

4.  Complement inhibitors and immunoconglutinins in ulcerative colitis and Crohn's disease.

Authors:  B J Potter; D J Brown; A Watson; D P Jewell
Journal:  Gut       Date:  1980-12       Impact factor: 23.059

5.  Ulcerative colitis--a disease characterised by the abnormal colonic epithelial cell?

Authors:  P R Gibson; E van de Pol; P J Barratt; W F Doe
Journal:  Gut       Date:  1988-04       Impact factor: 23.059

6.  Seropositivity in Dutch Crohn's disease patients against primed nude mouse lymph nodes, and the difference with lymphocytotoxic antibodies.

Authors:  A S Pena; I Kuiper; H C Walvoort; H W Verspaget; I T Weterman; E J Ruitenberg; K M Das
Journal:  Gut       Date:  1986-12       Impact factor: 23.059

7.  Raised titres of anti-klebsiella IgA in ankylosing spondylitis, rheumatoid arthritis, and inflammatory bowel disease.

Authors:  R Cooper; S M Fraser; R D Sturrock; C G Gemmell
Journal:  Br Med J (Clin Res Ed)       Date:  1988-05-21

8.  Production of peptides inducing chemotaxis and lysosomal enzyme release in human neutrophils by intestinal bacteria in vitro and in vivo.

Authors:  V S Chadwick; D M Mellor; D B Myers; A C Selden; A Keshavarzian; M F Broom; C H Hobson
Journal:  Scand J Gastroenterol       Date:  1988-01       Impact factor: 2.423

9.  Local immune mechanisms in inflammatory bowel disease and colorectal carcinoma. Natural killer cells and their activity.

Authors:  P R Gibson; D P Jewell
Journal:  Gastroenterology       Date:  1986-01       Impact factor: 22.682

10.  Diminished neutrophil function in Crohn's disease and ulcerative colitis identified by decreased oxidative metabolism and low superoxide dismutase content.

Authors:  H W Verspaget; A S Peña; I T Weterman; C B Lamers
Journal:  Gut       Date:  1988-02       Impact factor: 23.059
View more
  9 in total

1.  Characterisation and quantification of mucosal cytokine that induces epithelial histocompatibility locus antigen-DR expression in inflammatory bowel disease.

Authors:  J R Lowes; P Radwan; J D Priddle; D P Jewell
Journal:  Gut       Date:  1992-03       Impact factor: 23.059

2.  Quantification of inflammatory mediators in stool samples of patients with inflammatory bowel disorders and controls.

Authors:  S C Bischoff; J Grabowsky; M P Manns
Journal:  Dig Dis Sci       Date:  1997-02       Impact factor: 3.199

3.  Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses.

Authors:  D J Berg; N Davidson; R Kühn; W Müller; S Menon; G Holland; L Thompson-Snipes; M W Leach; D Rennick
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

Review 4.  Lymphocyte and macrophage interleukin receptors in inflammatory bowel disease: a more selective target for therapy?

Authors:  M J Weldon; J D Maxwell
Journal:  Gut       Date:  1994-07       Impact factor: 23.059

5.  Interleukin 16 expression and phenotype of interleukin 16 producing cells in Crohn's disease.

Authors:  P Middel; K Reich; F Polzien; V Blaschke; B Hemmerlein; J Herms; M Korabiowska; H J Radzun
Journal:  Gut       Date:  2001-12       Impact factor: 23.059

6.  Human colonic intraepithelial lymphocytes from patients with inflammatory bowel disease fail to down-regulate proliferative responses of primed allogeneic peripheral blood mononuclear cells after rechallenge with antigens.

Authors:  H R Dalton; M C Dipaolo; G K Sachdev; B Crotty; P Hoang; D P Jewell
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

7.  Selective expansion of specific T cell receptors in the inflamed colon of Crohn's disease.

Authors:  B Gulwani-Akolkar; P N Akolkar; A Minassian; R Pergolizzi; M McKinley; G Mullin; S Fisher; J Silver
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

8.  Analysis of T-lymphocyte subpopulations in inflammatory bowel diseases by three-color flow cytometry.

Authors:  G A Neil; R W Summers; B A Cheyne; C Carpenter; W L Huang; T J Waldschmidt
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199

Review 9.  Inflammatory mediators in chronic inflammatory bowel diseases.

Authors:  V Gross; T Andus; H G Leser; M Roth; J Schölmerich
Journal:  Klin Wochenschr       Date:  1991-12-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.